BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22899289)

  • 21. The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments.
    Gefeller O; Kaiser I; Brockmann EM; Uter W; Pfahlberg AB
    Curr Oncol; 2024 Apr; 31(4):2221-2232. PubMed ID: 38668067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients.
    Broggi MAS; Maillat L; Clement CC; Bordry N; Corthésy P; Auger A; Matter M; Hamelin R; Potin L; Demurtas D; Romano E; Harari A; Speiser DE; Santambrogio L; Swartz MA
    J Exp Med; 2019 May; 216(5):1091-1107. PubMed ID: 30975896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.
    Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A
    Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRAME/MELAN-A double immunostaining as a diagnostic tool for conjunctival melanocytic lesions: A South American experience.
    Carvajal P; Zoroquiain P
    Pathol Res Pract; 2023 Oct; 250():154776. PubMed ID: 37696245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
    Donati M; Grossmann P; Mansour B; Kazakov DV
    Am J Dermatopathol; 2024 Feb; 46(2):107-110. PubMed ID: 37982490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric Melanoma Arising in a Background of Melanocytic Nevi.
    Jamir TS; Khonglah Y; Harris C; Lynser D
    Indian Dermatol Online J; 2024; 15(1):89-91. PubMed ID: 38283032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of DLEC1 D215N Somatic Mutation in Formalin Fixed Paraffin Embedded Melanoma and Melanocytic Nevi Specimens.
    Vieira R; Simões MJ; Carmona S; Egas C; Faro C; Figueiredo A
    J Skin Cancer; 2013; 2013():469671. PubMed ID: 24222856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDH22 expression is reduced in metastatic melanoma.
    Piche B; Khosravi S; Martinka M; Ho V; Li G
    Am J Cancer Res; 2011; 1(2):233-239. PubMed ID: 21969168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-nodal basin drainage in lower limb melanoma.
    Hague A; Platford B; Rehman SU; Howes AJ; Brackley P
    JPRAS Open; 2024 Mar; 39():71-74. PubMed ID: 38111715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging Mass Spectrometry-Based Proteomic Analysis to Differentiate Melanocytic Nevi and Malignant Melanoma.
    Casadonte R; Kriegsmann M; Kriegsmann K; Hauk I; Meliß RR; Müller CSL; Kriegsmann J
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Quantitative Proteomic Analysis of Melanoma Subtypes, Nevus-Associated Melanoma, and Corresponding Nevi.
    Naimy S; Sølberg JBK; Kuczek DE; Løvendorf MB; Bzorek M; Litman T; Mund A; Rahbek Gjerdrum LM; Clark RA; Mann M; Dyring-Andersen B
    J Invest Dermatol; 2024 Jan; ():. PubMed ID: 38185415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma.
    Forchhammer S; Aebischer V; Lenders D; Seitz CM; Schroeder C; Liebmann A; Abele M; Wild H; Bien E; Krawczyk M; Schneider DT; Brecht IB; Flatz L; Hahn M
    Pigment Cell Melanoma Res; 2024 Mar; ():. PubMed ID: 38509752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of sequencing for ATP6AP1 and ATP6AP2 to distinguish between atypical granular cell tumor with junctional component and melanoma.
    Warren SJ; Alomari AK
    J Cutan Pathol; 2023 Nov; 50(11):1014-1019. PubMed ID: 37565535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX-10 and TRP-1 expression in feline ocular and nonocular melanomas.
    Orlandi M; Porcellato I; Sforna M; Lo Giudice A; Giglia G; Mechelli L; Brachelente C
    Vet Pathol; 2024 Apr; ():3009858241244850. PubMed ID: 38613415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular skin fluorescence imaging: A tool for evaluating early melanoma development.
    Shachaf A; Manbeck K; Yang G; Shachaf C
    Pigment Cell Melanoma Res; 2024 May; 37(3):372-377. PubMed ID: 38178654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photothermal multispectral image cytometry for quantitative histology of nanoparticles and micrometastasis in intact, stained and selectively burned tissues.
    Nedosekin DA; Shashkov EV; Galanzha EI; Hennings L; Zharov VP
    Cytometry A; 2010 Nov; 77(11):1049-58. PubMed ID: 20949577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms.
    Linos K
    J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile of SIRT2 in human melanoma and implications for sirtuin-based chemotherapy.
    Wilking-Busch MJ; Ndiaye MA; Huang W; Ahmad N
    Cell Cycle; 2017 Mar; 16(6):574-577. PubMed ID: 28166441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma.
    Su D; Djureinovic D; Schoenfeld D; Marquez-Nostra B; Olino K; Jilaveanu L; Kluger H
    Res Sq; 2023 Sep; ():. PubMed ID: 37790306
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.